Back to Trades
Grant4
Evommune, Inc.
EVMN
Total Value
$1000.0K
Grants
$1000.0K
1 transaction
Company Information
- Company Name
- Evommune, Inc.
- Ticker Symbol
- EVMN
- CIK
- 0002044725
Insider Information
- Role
- Insider
- Location
- BOSTON, MA
Filing Details
- Filing Date
- Feb 17, 2026
- Transaction Date
- Feb 17, 2026
- Accession Number
- 0001231919-26-000164
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Feb 17, 2026 | Common Stock | 35,868 | $27.88 | Grant/Award | $1000.0K |
Footnotes
- (F1)RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund") and RA Capital Nexus Fund III, L.P. (the "Nexus Fund III"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. Each of the Adviser, the Adviser GP, the Fund, the Nexus Fund III, Dr. Kolchinsky and Mr. Shah disclaims beneficial ownership of any of the reported securities, except to the extent of its or his respective pecuniary interest therein.
- (F2)Held directly by the Fund.
- (F3)Held directly by the Nexus Fund III.